Surgical and Functional Outcomes of Rectourethral Fistulas Surgery With Gracilis Flap Interposition After Localized Prostatic Cancer Treatment. (GRA-FUR)
Status
Conditions
Treatments
Details and patient eligibility
About
Prostate cancer is the first cancer amongst men with more than 50000 cases per year in France. Surgical, radiation, frost, or ultrasound induced rectourethral fistula is a rare complication (<1%) of localized prostatic cancer treatment but hard to manage. Different types of treatment exist: conservatory, trans-sphinteric (York-Masson), transanal, perineal, with or without muscle flap interposition. Gracilis flap interposition for rectourethral fistula management is a promising technique but few cases are described and functional results are scarce.
The aim of this study is to present surgical and functional outcomes of rectourethral fistulas surgery with gracilis flap interposition after treatment of localized prostate cancer.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Male over 18 years old
- Treated for a localized prostatic cancer (Prostatectomy, cryotherapy, HIFU, radiotherapy)
- Affected with a treatment induced Rectourethral fistula
Exclusion criteria
- Rectourethral fistula caused by other pelvic diseases (gynecological or digestif cancer, inflammatory bowel disease, other urogenital issues)
- Rectourethral fistula treated by cysto-prostatectomy with urinary tract derivation
- Patient under guardianship
- Non comprehension of written or spoken French
Trial design
17 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal